Skip to content

Clinical trials

Thalassemia trials in Lebanon

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thalassemia Country / region: Lebanon Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20071
20081
20143
20151
20172
20181
20201
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals7
Ala'a Sharara1
Celgene1
Forma Therapeutics, Inc.1
Ionis Pharmaceuticals, Inc.1
Novartis1
Novo Nordisk A/S1
Sideris Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thalassemia14
beta-Thalassemia7
Iron Overload4
Myelodysplastic Syndromes3
Anemia2
Anemia, Diamond-Blackfan2
Anemia, Sickle Cell2
alpha-Thalassemia2
Anemia, Hemolytic1
Anemia, Sideroblastic1

Trials

Showing 51 to 14 of 14. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.